H. Allgayer

1.3k total citations
48 papers, 965 citations indexed

About

H. Allgayer is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, H. Allgayer has authored 48 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 18 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in H. Allgayer's work include Helicobacter pylori-related gastroenterology studies (10 papers), Drug Transport and Resistance Mechanisms (8 papers) and Inflammatory Bowel Disease (8 papers). H. Allgayer is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (10 papers), Drug Transport and Resistance Mechanisms (8 papers) and Inflammatory Bowel Disease (8 papers). H. Allgayer collaborates with scholars based in Germany, United States and Austria. H. Allgayer's co-authors include Wolfgang Kruis, William F. Stenson, R Gugler, Katherine DeSchryver, G. Paumgartner, Christoph F. Dietrich, S Schreiber, Ulrich Klotz, W. Rohde and J Eisenburg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Diabetologia.

In The Last Decade

H. Allgayer

45 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Allgayer Germany 17 303 296 251 167 160 48 965
A.R. Tanner United Kingdom 20 314 1.0× 213 0.7× 121 0.5× 168 1.0× 314 2.0× 47 1.3k
Harold D. Frankl United States 16 369 1.2× 334 1.1× 300 1.2× 333 2.0× 247 1.5× 23 1.6k
J.P. Desager Belgium 18 189 0.6× 122 0.4× 139 0.6× 130 0.8× 133 0.8× 68 1.1k
Warren P. Bishop United States 20 468 1.5× 239 0.8× 130 0.5× 440 2.6× 91 0.6× 75 1.5k
S Bondesen Denmark 25 641 2.1× 243 0.8× 705 2.8× 144 0.9× 529 3.3× 50 1.8k
Klaus Kutz Switzerland 21 320 1.1× 304 1.0× 64 0.3× 297 1.8× 292 1.8× 59 1.8k
G. M. Murphy United Kingdom 26 638 2.1× 598 2.0× 87 0.3× 275 1.6× 341 2.1× 65 1.8k
Hyeong‐Seok Lim South Korea 21 280 0.9× 795 2.7× 208 0.8× 622 3.7× 129 0.8× 91 1.9k
Fusao Komada Japan 21 146 0.5× 309 1.0× 50 0.2× 391 2.3× 89 0.6× 67 1.3k
Dominique Werner Switzerland 21 139 0.5× 373 1.3× 70 0.3× 427 2.6× 64 0.4× 49 1.3k

Countries citing papers authored by H. Allgayer

Since Specialization
Citations

This map shows the geographic impact of H. Allgayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Allgayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Allgayer more than expected).

Fields of papers citing papers by H. Allgayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Allgayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Allgayer. The network helps show where H. Allgayer may publish in the future.

Co-authorship network of co-authors of H. Allgayer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Allgayer. A scholar is included among the top collaborators of H. Allgayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Allgayer. H. Allgayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allgayer, H., Robert W. Owen, Joachim Wiskemann, et al.. (2021). Tumor risk biomarkers and physical activity in type 2 diabetes, patients with colorectal cancer and individuals without diabetes. SHILAP Revista de lepidopterología. 3. 100091–100091.
2.
Faller, Hermann, et al.. (2009). Effectiveness of education for gastric cancer patients. Patient Education and Counseling. 76(1). 91–98. 14 indexed citations
3.
Allgayer, H., A Ignee, & Christoph F. Dietrich. (2009). Endosonographic elastography of the anal sphincter in patients with fecal incontinence. Scandinavian Journal of Gastroenterology. 45(1). 30–38. 22 indexed citations
4.
5.
Allgayer, H. & Christoph F. Dietrich. (2008). Einheimische Sprue und Malignomrisiko. Medizinische Klinik. 103(8). 561–568. 3 indexed citations
6.
Allgayer, H., Wolfgang Holtmeier, & Christoph F. Dietrich. (2007). [Crohn's disease and cancer risk. Incidence/prevalence, clinical characteristics, and potential prevention strategies].. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 102(9). 727–733.
7.
Allgayer, H., Wolfgang Holtmeier, & Christoph F. Dietrich. (2007). Morbus Crohn und Malignomrisiko. Medizinische Klinik. 102(9). 727–733. 1 indexed citations
8.
9.
Allgayer, H.. (2003). Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 18(s2). 10–14. 87 indexed citations
10.
Allgayer, H., et al.. (2002). Effects of bile acids on base hydroxylation in a model of human colonic mucosal DNA. Cancer Detection and Prevention. 26(1). 85–89. 9 indexed citations
11.
Allgayer, H. & Wolfgang Kruis. (2002). Aminosalicylates: Potential Antineoplastic Actions in Colon Cancer Prevention. Scandinavian Journal of Gastroenterology. 37(2). 125–131. 20 indexed citations
12.
Allgayer, H., Thomas Tillmann, Andreas Hombach, W Kruis, & Christof Pohl. (2000). Aminosalizylate und Aspirin bei Kolonkarzinomen: vom Entzündungshemmer zum Tumorprophylaktikum?. Zeitschrift für Gastroenterologie. 38(12). 963–970. 1 indexed citations
13.
Allgayer, H., et al.. (1999). Modulation of Base Hydroxylation by Bile Acids and Salicylates in a Model of Human Colonic Mucosal DNA (Putative Implications in Colonic Cancer). Digestive Diseases and Sciences. 44(4). 761–767. 11 indexed citations
14.
Scheurlen, Christian, H. Allgayer, Wolfgang Kruis, Erland Erdmann, & Tilman Sauerbruch. (1993). Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. Journal of Molecular Medicine. 71(4). 286–9. 14 indexed citations
15.
Allgayer, H.. (1991). Clinical relevance of oxygen radicals in inflammatory bowel disease — Facts and fashion. Journal of Molecular Medicine. 69(21-23). 1001–1003. 24 indexed citations
16.
Gugler, R & H. Allgayer. (1990). Effects of Antacids on the Clinical Pharmacokinetics of Drugs. Clinical Pharmacokinetics. 18(3). 210–219. 76 indexed citations
17.
Allgayer, H., et al.. (1989). Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease. Gastroenterology. 97(1). 38–41. 75 indexed citations
18.
Allgayer, H. & William F. Stenson. (1988). A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid. Immunopharmacology. 15(1). 39–46. 25 indexed citations
19.
Allgayer, H., Wolfgang Kruis, G. Paumgartner, et al.. (1988). Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease. Digestive Diseases and Sciences. 33(4). 417–422. 38 indexed citations
20.
Allgayer, H. & G. Paumgartner. (1983). Studies on the in vitro interaction of D-penicillamine with antacids.. PubMed. 33(3). 417–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.R. Tanner Breakdown of academic impact, for papers by Harold D. Frankl Breakdown of academic impact, for papers by J.P. Desager Breakdown of academic impact, for papers by Warren P. Bishop Breakdown of academic impact, for papers by S Bondesen Breakdown of academic impact, for papers by Klaus Kutz Breakdown of academic impact, for papers by G. M. Murphy Breakdown of academic impact, for papers by Hyeong‐Seok Lim Breakdown of academic impact, for papers by Fusao Komada Breakdown of academic impact, for papers by Dominique Werner
Rankless by CCL
2026